|
KETEK
Health authorities are investigating the use of antibiotic Ketek after one patient died and another required a liver transplant.
Ketek is in a class of ketolide antibiotics used to treat bacterial infections such as pneumonia, chronic bronchitis, and acute bacterial sinusitis. Sanofi-Aventis launched Ketek in 2004 and is currently distributing it worldwide.
Other known side effects of Ketek include hepatic dysfunction, jaundice, drowsiness, dizziness, blurred vision or double vision, and nausea.
As authorities are running an investigation of Ketek, medical professionals warn patients taking Ketek to talk to their doctor about any side effects and any prior history of liver disease or kidney dysfunction.
KETEK NEWS
Douglas Loveland, a special agent at the FDA's criminal-investigation office, told the House Energy and Commerce investigations subcommittee that the company "should have" known some results were sloppy and fraudulent. (Feb-12-07) Wall Street Journal: Ketek Liver Damage
Forty-seven people have filed suit against Sanofi-Aventis, claiming that they knew that Ketek put users at an increased risk of injuries or death from liver failure. (Nov-28-07) News Inferno: Ketek Liver Damage
Food and Drug Administration advisory committee recomments that use of Sanofi-aventis' antibiotic Ketek should be limited due to liver failure. (Dec-18-06) Science Daily: Ketek Liver Damage
|
 |
|
